Pharmaceutical Manufacturer 340B Price Restriction Chart Updated
Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary
Fighting to Preserve the Benefits of the 340B Program
Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary
View and share the PDF Version Here. PRESS STATEMENT: FOR IMMEDIATE RELEASE National Ryan White Clinic Organization Calls on State of New York to Reverse Medicaid Pharmacy Budget Gimmick, Support…
View as PDF 340B STATEMENT OF PRINCIPLES RWC-340B is a national association of HIV/AIDS clinics and service providers that receive support under the Ryan White Comprehensive AIDS Resources…
RWC-340B Statement Regarding ASAP 340B Core Principles After carefully considering the ASAP 340B discussion draft and accompanying materials, RWC-340B is opposed to the proposal as written. We are especially…
See RWC-340B’s updated chart below: (Updated 02.22.23) Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary (D1049682)
RWC-340B Members, Dr. John Carlo of Prism Health and David Poole of AHF, are quoted throughout the linked article, displaying the many challenges faced by clinics navigating changes in PrEP…
Explore the fundamentals of 340B with experts from the field. Key Topics: -History and purpose of the 340B program -How 340B program acts as a taxpayer relief program -340B eligibility…
RWC-340B releases analysis warning federal and state policymakers of drug industry disinformation campaign. “RWC-340B will not stand idle while the pharmaceutical industry attacks safety net providers in the 340B…
RWC-340B President, Shannon Stephenson, submitted comments to HRSA in response to the Information Collection Request (ICR), issued by the Health Resources and Services Administration (HRSA). In the submission, RWC-340B made…
Click below to see RWC-340B’s Press Statement PrEP BIll Press Statement RWC-340B